### ü´Å Pulmonology: Pulmonary Sarcoidosis Management

#### ‚úÖ True Statements
1. **Sarcoidosis** is a **granulomatous disease of unknown cause** that can affect any organ system, with **>90% of patients having lung involvement**.
2. **Pulmonary sarcoidosis** is classified into **four stages** based on **chest radiograph appearance**.
3. **Treatment decisions** in pulmonary sarcoidosis are based on **symptoms and degree of organ dysfunction**, not radiographic findings.
4. **Glucocorticoids** such as **prednisone** are the **primary treatment** for **symptomatic pulmonary sarcoidosis**.
5. **Adjunctive glucocorticoid-sparing therapies** are used in pulmonary sarcoidosis if patients cannot tolerate glucocorticoids or remain symptomatic despite them.
6. **Surgical lung biopsy** is rarely warranted in suspected sarcoidosis because **bronchoscopic sampling** of lymph nodes or lung tissue has a **high diagnostic yield**.
7. **Clinical observation** without therapy is appropriate in pulmonary sarcoidosis patients **without symptoms or organ dysfunction**, as spontaneous resolution is common.
8. **Nintedanib**, an antifibrotic agent used in idiopathic pulmonary fibrosis and connective tissue disease‚Äìassociated interstitial lung disease, **has no role in treating pulmonary sarcoidosis**.

#### üí¨ Extra
1. Stage II pulmonary sarcoidosis shows **bilateral symmetric hilar and right paratracheal lymphadenopathy** with **parenchymal involvement**.
7. The likelihood of spontaneous resolution in pulmonary sarcoidosis is related to the **radiographic stage**.

#### üè∑Ô∏è Tags
#Pulmonology #AmbulatoryCare #Sarcoidosis #GranulomatousDisease #Glucocorticoids #Prednisone #Bronchoscopy

#### üìö Reference
Belperio JA, Shaikh F, Abtin FG, et al. Diagnosis and treatment of pulmonary sarcoidosis: a review. *JAMA*. 2022;327:856-67. PMID: 35230389 doi:10.1001/jama.2022.1570

#### üÜî Question ID
PMMCQ24018

#### üïí Last Updated
February 2025

---

#### üìñ Related Text
MKSAP 19: Pulmonary Medicine ‚Äî Diffuse Parenchymal Lung Disease, Sarcoidosis

---

### üìò Related Text Derivations

#### ‚úÖ True Statements ‚Äî Sarcoidosis
1. The **prevalence of sarcoidosis** is approximately **10‚Äì20 per 100,000 individuals**.
2. **More than 90%** of patients with sarcoidosis have **lung involvement**.
3. On imaging, **nodules along bronchovascular bundles on high-resolution computed tomography (HRCT)** suggest sarcoidosis.
4. **Chest radiograph findings** can help predict the **probability of spontaneous resolution**.
5. **Pulmonary function testing** in sarcoidosis is typically **abnormal** and can show **obstructive, restrictive, or mixed patterns**.
6. **Sarcoidosis is a diagnosis of exclusion**, requiring noncaseating granulomas plus exclusion of infections (eg, mycobacteria, fungi) and other systemic granulomatous diseases.
7. Diagnosis of sarcoidosis ideally includes **evidence of involvement of more than one organ system**.
8. **Glucocorticoids** are the **primary treatment** of sarcoidosis, although many patients do **not require treatment**.
9. The decision to treat sarcoidosis and assessment of response should be based on **symptoms and organ dysfunction**, not radiographic findings.
10. **Pulmonary hypertension** in sarcoidosis is a **poor prognostic indicator**, with a **median survival of ~3 years**.
11. **Pulmonary consultation** should be considered for persistent sarcoidosis.
12. **Evaluation for lung transplantation** is appropriate in sarcoidosis with **pulmonary hypertension** or **severe disease with significant activity limitation**.

#### üí¨ Extra
6. Bronchoscopic biopsy is the **usual diagnostic approach** for tissue confirmation in sarcoidosis, except in syndromes that do not require biopsy.
10. Pulmonary hypertension worsens prognosis in sarcoidosis independent of other lung involvement.

#### üè∑Ô∏è Tags
#Sarcoidosis #GranulomatousDisease #Pulmonology #PulmonaryHypertension #LungTransplantation #Bronchoscopy #HRCT

---

#### üñºÔ∏è Supplemental Figures

<figure>
  <img src="Hilar Lymphadenopathy on Chest Radiograph in Stage I Pulmonary Sarcoidosis.jpg" alt="Chest radiograph showing stage I pulmonary sarcoidosis with hilar lymphadenopathy and normal lung parenchyma.">
  <figcaption><strong>Hilar Lymphadenopathy on Chest Radiograph in Stage I Pulmonary Sarcoidosis.</strong> Chest radiograph showing stage I pulmonary sarcoidosis with hilar lymphadenopathy and normal lung parenchyma.</figcaption>
</figure>

---

#### üóæ Supplemental Tables

<!-- Table 1: Radiographic Characteristics and Staging -->
<table>
  <caption><strong>Radiographic Characteristics and Staging in Pulmonary Sarcoidosis</strong></caption>
  <thead>
    <tr>
      <th>Stage</th>
      <th>Radiographic Pattern</th>
      <th>Clinical Course and Comments</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>0</td>
      <td>Normal</td>
      <td>‚Äî</td>
    </tr>
    <tr>
      <td>I</td>
      <td>Hilar lymphadenopathy with normal lung parenchyma</td>
      <td>&gt;90% rate of spontaneous resolution without treatment</td>
    </tr>
    <tr>
      <td>II</td>
      <td>Hilar lymphadenopathy with abnormal lung parenchyma</td>
      <td>Approximately 50% rate of spontaneous improvement without treatment</td>
    </tr>
    <tr>
      <td>III</td>
      <td>No lymphadenopathy with abnormal lung parenchyma</td>
      <td>Approximately 20% rate of spontaneous improvement without treatment</td>
    </tr>
    <tr>
      <td>IV</td>
      <td>Parenchymal changes with fibrosis and architectural distortion</td>
      <td>‚Äî</td>
    </tr>
  </tbody>
</table>

#### ‚úÖ True Statements (from Table: Radiographic Characteristics and Staging in Pulmonary Sarcoidosis)
1. **Stage I pulmonary sarcoidosis** shows **hilar lymphadenopathy with normal lung parenchyma** and has a **>90% spontaneous resolution rate** without treatment.
2. **Stage II pulmonary sarcoidosis** combines **hilar lymphadenopathy** with **abnormal lung parenchyma** and has an **~50% spontaneous improvement rate** without treatment.
3. **Stage III pulmonary sarcoidosis** features **abnormal lung parenchyma without lymphadenopathy** and has an **~20% spontaneous improvement rate** without treatment.
4. **Stage IV pulmonary sarcoidosis** is characterized by **parenchymal fibrosis with architectural distortion**.
5. **Radiographic staging (0‚ÄìIV)** does **not determine treatment**, which is based on **symptoms and organ dysfunction**.

#### üí¨ Extra (Table: Radiographic Characteristics and Staging)
1. Spontaneous improvement rates **decrease** from stage I to stage III; stage IV reflects **fibrotic, less reversible disease**.

---

<!-- Table 2: Clinical Presentations That Do Not Require Biopsy -->
<table>
  <caption><strong>Clinical Presentations of Sarcoidosis That Do Not Require Biopsy</strong></caption>
  <thead>
    <tr>
      <th>Syndrome</th>
      <th>Additional Findings/Symptoms</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td>Asymptomatic bilateral hilar lymphadenopathy</td>
      <td>No evidence of fevers, malaise, weight loss, or night sweats to suggest a malignancy or infection</td>
    </tr>
    <tr>
      <td>L√∂fgren syndrome</td>
      <td>Bilateral hilar lymphadenopathy, migratory polyarthralgia, erythema nodosum, fever</td>
    </tr>
    <tr>
      <td>Heerfordt syndrome</td>
      <td>Anterior uveitis, parotitis, fever (uveoparotid fever), facial nerve palsy</td>
    </tr>
  </tbody>
</table>

#### ‚úÖ True Statements (from Table: Clinical Presentations of Sarcoidosis That Do Not Require Biopsy)
1. **Asymptomatic bilateral hilar lymphadenopathy** without constitutional symptoms (fever, malaise, weight loss, night sweats) can establish sarcoidosis **without tissue biopsy**.
2. **L√∂fgren syndrome**‚Äîdefined by **bilateral hilar lymphadenopathy**, **migratory polyarthralgia**, **erythema nodosum**, and **fever**‚Äîdoes **not require biopsy** for sarcoidosis diagnosis.
3. **Heerfordt syndrome**‚Äî**anterior uveitis**, **parotitis**, **fever (uveoparotid fever)**, and **facial nerve palsy**‚Äîdoes **not require biopsy** for sarcoidosis diagnosis.

#### üè∑Ô∏è Tags (Tables)
#Sarcoidosis #ChestRadiograph #HilarLymphadenopathy #LofgrenSyndrome #HeerfordtSyndrome #BiopsyNotRequired
